Hydrapres Statistics

Total Valuation

Hydrapres has a market cap or net worth of PLN 20.84 million. The enterprise value is 25.89 million.

Market Cap	20.84M
Enterprise Value	25.89M

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Hydrapres has 35.93 million shares outstanding.

Current Share Class	35.93M
Shares Outstanding	35.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.64
PB Ratio	3.74
P/TBV Ratio	3.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.64
EV / Sales	0.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.87

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.15.

Current Ratio	0.91
Quick Ratio	0.46
Debt / Equity	1.15
Debt / EBITDA	n/a
Debt / FCF	-2.20
Interest Coverage	-2.80

Financial Efficiency

Return on equity (ROE) is -66.48% and return on invested capital (ROIC) is -17.43%.

Return on Equity (ROE)	-66.48%
Return on Assets (ROA)	-7.74%
Return on Invested Capital (ROIC)	-17.43%
Return on Capital Employed (ROCE)	-29.69%
Revenue Per Employee	371,818
Profits Per Employee	-64,110
Employee Count	87
Asset Turnover	1.06
Inventory Turnover	3.96

Taxes

In the past 12 months, Hydrapres has paid 50,065 in taxes.

Income Tax	50,065
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.89% in the last 52 weeks. The beta is -0.04, so Hydrapres's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	+28.89%
50-Day Moving Average	0.51
200-Day Moving Average	0.46
Relative Strength Index (RSI)	71.76
Average Volume (20 Days)	841

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hydrapres had revenue of PLN 32.35 million and -5.58 million in losses. Loss per share was -0.16.

Revenue	32.35M
Gross Profit	585,759
Operating Income	-3.79M
Pretax Income	-5.53M
Net Income	-5.58M
EBITDA	-2.18M
EBIT	-3.79M
Loss Per Share	-0.16

Full Income Statement

Balance Sheet

The company has 1.37 million in cash and 6.41 million in debt, giving a net cash position of -5.05 million or -0.14 per share.

Cash & Cash Equivalents	1.37M
Total Debt	6.41M
Net Cash	-5.05M
Net Cash Per Share	-0.14
Equity (Book Value)	5.57M
Book Value Per Share	0.16
Working Capital	-1.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.71 million and capital expenditures -208,068, giving a free cash flow of -2.92 million.

Operating Cash Flow	-2.71M
Capital Expenditures	-208,068
Free Cash Flow	-2.92M
FCF Per Share	-0.08

Full Cash Flow Statement

Margins

Gross margin is 1.81%, with operating and profit margins of -11.73% and -17.24%.

Gross Margin	1.81%
Operating Margin	-11.73%
Pretax Margin	-17.09%
Profit Margin	-17.24%
EBITDA Margin	-6.75%
EBIT Margin	-11.73%
FCF Margin	n/a

Dividends & Yields

Hydrapres does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-26.76%
FCF Yield	-14.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hydrapres has an Altman Z-Score of 0.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.68
Piotroski F-Score	3